SEC Filing Analysis: Werewolf Therapeutics, Inc. (null)

Executive Summary

• Trading Significance: Low
• Key Takeaway: MPM Asset Management, a significant shareholder, has filed a notice of proposed sale for a de minimis amount of stock ($5,867) under a pre-scheduled 10b5-1 trading plan.
• Market Impact: The transaction is negligible and expected to have no impact on the stock.

Company Information

Field	Value
Company	Werewolf Therapeutics, Inc.
Ticker Symbol	null
CIK	0001785530
Industry	PHARMACEUTICAL PREPARATIONS

Insider Information

Field	Value
Name	MPM Asset Management Investors BV2014 LLC
CIK	0001609495
Title/Position	null
Relationship	Shareholder

Transaction Details

Field	Value
Form Type	144
Transaction Date	2025-11-04
Transaction Code	S
Security Type	Common Stock
Shares Involved	4479
Price Per Share	$1.31
Total Value	$5867.49
Shares Owned After	null
Ownership Type	Indirect

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$5,867.49
% of Market Cap	0.0098%
Shares Transacted	4,479
% of Shares Outstanding	0.0098%
Post-Transaction Ownership	Not Available
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a $60 million market capitalization, this transaction of less than $6,000 is financially insignificant.
• Ownership Concentration: While filed by a major institutional shareholder, the size of this specific sale is too small to affect ownership concentration meaningfully.
• Transaction Significance: The sale is well below the thresholds for moderate significance (>0.1% of market cap or shares outstanding). Its primary relevance is noting the existence of an active 10b5-1 plan for the filer.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction size is immaterial. As a notice of a proposed sale under a 10b5-1 plan, it does not signal any new negative sentiment from the insider.

Volume & Sentiment

• Expected Volume Impact: None. The number of shares is trivial compared to typical daily trading volume.
• Sentiment Indicator: Neutral. This is a routine, pre-planned transaction with no informational value for investors.

Additional Context

Special Circumstances

• This filing was made pursuant to a Rule 10b5-1 trading plan adopted on September 24, 2025. This indicates the decision to sell was made well in advance and is not a reaction to current events.